Potential Linkage Between DPP‐4 Inhibitor Use and the Risk of Pancreatitis/Pancreatic Cancer

Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.13192
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Chronic Pancreatitis and Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2014English

Inflammation and Cancer v. Chronic Pancreatitis and Pancreatic Cancer

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2004English

Pancreatic Enzyme Replacement Therapy in the Course of Chronic Pancreatitis and Pancreatic Cancer

Effective Pharmacotherapy
2019English

Association Between Pancreatic Cancer and Dipeptidyl Peptidase-4 Inhibitors Use in a Case-Control Study

Mayo Clinic Proceedings
Medicine
2018English

Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes

Prescriber
Pharmacology
2017English

DPP-4 Inhibitor-Associated Bullous Pemphigoid in a Hemodialysis Patient

Internal Medicine
Internal MedicineMedicine
2020English

Potential for Differential Diagnosis of Autoimmune Pancreatitis and Pancreatic Cancer Using Carbonic Anhydrase II Antibody

Suizo
2008English

DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes

Prescriber
Pharmacology
2017English

Dipeptidyl Peptidase-4 Inhibitors, Pancreatic Cancer and Acute Pancreatitis: A Meta-Analysis With Trial Sequential Analysis

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy